ANI Pharmaceuticals, Inc. (ANIP)
81.98
+0.31
(+0.38%)
USD |
NASDAQ |
Dec 10, 15:39
ANI Pharmaceuticals Total Assets (Quarterly): 1.408B for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| CorMedix, Inc. | 750.86M |
| Arcutis Biotherapeutics, Inc. | 370.98M |
| Intellia Therapeutics, Inc. | 925.28M |
| Beam Therapeutics, Inc. | 1.311B |
| Halozyme Therapeutics, Inc. | 2.221B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 902.34M |
| Shareholders Equity (Quarterly) | 505.82M |
| Debt to Equity Ratio | 1.249 |
| Current Ratio | 2.581 |
| Net Debt Paydown Yield | -3.12% |